Royal Bank of Canada
GNCA

Royal Bank of Canada’s Genocea Biosciences, Inc. GNCA Stock Holding History

Royal Bank of Canada’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1
Closed – – 7403
2019
Q3 		$0 Hold
1
– – ﹤0.01% 7477
2019
Q2 		$0 Sell
1
-879
-100% -$4.58K ﹤0.01% 7443
2019
Q1 		$4K Buy
880
+813
+1,213% +$4.02K ﹤0.01% 6395
2018
Q4 		$0 Hold
67
– – ﹤0.01% 7439
2018
Q3 		$0 Hold
67
– – ﹤0.01% 7155
2018
Q2 		$0 Sell
67
-1
-1% -$7 ﹤0.01% 6958
2018
Q1 		$1K Sell
68
-8
-11% -$66 ﹤0.01% 6264
2017
Q4 		$1K Sell
76
-306
-80% -$3.08K ﹤0.01% 6472
2017
Q3 		$5K Buy
382
+316
+479% +$12K ﹤0.01% 6443
2017
Q2 		$3K Buy
66
+2
+3% +$96 ﹤0.01% 6223
2017
Q1 		$3K Buy
64
+1
+2% +$39 ﹤0.01% 6390
2016
Q4 		$2K Hold
63
– – ﹤0.01% 6508
2016
Q3 		$3K Sell
63
-175
-74% -$6.87K ﹤0.01% 6129
2016
Q2 		$8K Buy
238
+125
+111% +$4.58K ﹤0.01% 5827
2016
Q1 		$7K Sell
113
-10
-8% -$318 ﹤0.01% 5857
2015
Q4 		$5K Sell
123
-64
-34% -$3.05K ﹤0.01% 6184
2015
Q3 		$11K Sell
187
-41
-18% -$4.07K ﹤0.01% 5861
2015
Q2 		$25K Buy
+228
New +$21.2K ﹤0.01% 5598
2015
Q1 		– Sell
-3
Closed – – 6548
2014
Q4 		$0 Buy
+3
New +$205 ﹤0.01% 6390

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Royal Bank of Canada's GNCA Position: Q4 2019 in Review

Royal Bank of Canada sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2019, closing a stake of 1 share.

Royal Bank of Canada first reported a position in GNCA in Q4 2014 and held it in 19 quarters. The position peaked at $25K in Q2 2015. 34 funds tracked by Wall St. Rank hold GNCA as of Q4 2019.

  • Royal Bank of Canada reported no remaining Genocea Biosciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Genocea Biosciences, Inc. share in Q4 2019.
  • Royal Bank of Canada first reported a position in Genocea Biosciences, Inc. in Q4 2014 and held it in 19 quarters.
  • Royal Bank of Canada's Genocea Biosciences, Inc. position peaked at $25K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2019.

Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.